Korean J Obstet Gynecol.  2007 Mar;50(3):533-538.

The clinical responses of uterine artery embolization to treat uterine leiomyoma for 3 years

Affiliations
  • 1Department of Obstetrics and Gynecology, Myongji Hospital, College of Medicine, Kwandong University, Goyang, Korea. ryuky@kwandong.ac.kr
  • 2Department of Radiology, College of Medicine, Hanyang University, Seoul, Korea.

Abstract


OBJECTIVE
The aim of our study is to evaluate the effect of uterine artery embolization as primary treatment for symptomatic uterine fibroid
METHODS
From December 1999 to December 2004, 25 patients underwent uterine artery embolization for the treatment of uterine fibroid. The patients were followed up at regular intervals (at 1st, 3rd, 6th month and annual) for 3 years. The mean duration of follow-up was about 41 month (range; 41+/-15). During follow-up period, consecutive uterine and fibroid volume, and symptoms were checked.
RESULTS
The uterine volumes were significantly reduced by 27% (P=0.0238) after 3month. And the fibroid volumes were significantly reduced by 59% (P=0.0070) after 1month. The uterine volumes were significantly reduced by 27% (P=0.0082) after 3 years. And the fibroid volumes were significantly reduced by 60% (P=0.0445) after 3 years. All women reported noticeable improvement of menorrhagia after complete of follow up. But, two of nine women who had symptoms of dysmenorrhea or lower abdominal pain, showed no changes in symptoms
CONCLUSION
Uterine artery embolization appears to be effective in controlling symptoms, and substantially reducing uterine and fibroid volume with few complication after 3 years. However, long term follow-up will be necessary to establish the efficacy of this procedure.


MeSH Terms

Abdominal Pain
Dysmenorrhea
Female
Follow-Up Studies
Humans
Leiomyoma*
Menorrhagia
Uterine Artery Embolization*
Uterine Artery*
Full Text Links
  • KJOG
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr